Linked Life Data

20633180

Source:http://linkedlifedata.com/resource/pubmed/id/20633180

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2010-7-16
pubmed:abstractText
Upper limb spasticity affecting elbow, wrist, and finger flexors can be safely and effectively reduced with injections of botulinum toxin type-A (BoNT-A). It has been best studied in adults in the context of post-stroke spasticity. The clinical benefits include reduction in pain and deformity, improvement in washing and dressing the upper limb, and a reduction in caregiver burden (Class I evidence, recommendation level A). Some patients show improvement in function performed by active movement of the affected upper limb (Class III evidence, recommendation C), but predicting and measuring this is difficult, and further research is needed. An individually based approach to treatment and outcome measurement is preferred (Class IV, recommendation U). More research is needed to resolve many unknown issues of assessment and treatment, using research methods appropriate to the question.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1468-1331
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
17 Suppl 2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
74-93
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.
pubmed:affiliation
Neurosciences, Neuromuscular Division, University of California, San Diego, CA 92103-8465, USA. gsheean@ucsd.edu
pubmed:publicationType
Journal Article, Practice Guideline, Consensus Development Conference